You are here: Industry Insights > Innovate

News List

Sterling Pharma Solutions Appoints Ian Baxendale to Lead Team at Dudley, UK Site contractpharma
July 30, 2021
Baxendale has over 20 years of academic and industrial experience within organic synthesis.
Chief.AI launches pay-as-you-go AI platform for drug discovery pharmaceutical-technology
July 27, 2021
Machine learning operations platform Chief.AI, in partnership with the Medicines Discovery Catapult, has launched the first no-code, pay-as-you-go artificial intelligence (AI) platform for drug discovery.
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine prnasia
December 25, 2020
INOVIO announced the publication of peer-reviewed Phase 1 clinical data from the first cohort of 40 participants for its COVID-19 DNA vaccine candidate, INO-4800, in EClinicalMedicine, an open access clinical journal published by The Lancet.
Inovio initiates dosing in Phase II segment of Covid-19 therapy trial pharmaceutical-technology
December 09, 2020
Biotechnology firm Inovio has dosed the first participant in a Phase II segment of its Phase II / III INovio INO-4800 Vaccine Trial for Efficacy (INNOVATE) trial analysing its Covid-19 vaccine candidate, INO-4800.
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19 prnasia
December 08, 2020
INOVIO announced it has dosed its first subject in a Phase 2 clinical trial evaluating DNA medicine INO-4800, its COVID-19 vaccine candidate, as part of its Phase 2/3 clinical trial, called INNOVATE (INovio INO-4800 Vaccine Trial for Efficacy).
Novartis continues to innovate in CML biospectrumasia
June 16, 2019
Novartis International AG / Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna use and promising combination data with investigational compound asciminib (ABL001).
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs pharmafocusasia
December 03, 2018
QIAGEN N.V. and NeoGenomics, Inc. today announced a master service agreement to accelerate the availability of innovativ
Ligand Announces OmniAb® Partnership with iMetabolic Biopharma Corporation fiercepharma
November 22, 2018
Dr. Urban A. Kiernan, the Founder and Chief Executive Officer of iMetabolic Biopharma Corporation, stated, “The willingness of the Ligand team to execute this partnership deal clearly shows their understanding of the needs and value of early stage drug di
Cobra Biologics Awarded $3.4M by Innovate UK contractpharma
January 31, 2018
Cobra Biologics has been awarded £2.6 million ($3.4 million) capital infrastructure investment by Innovate UK.